OTTAWA, May 6
/PRNewswire-FirstCall/ - Hard to Treat Diseases Inc. (HTDS;
http://www.htds medical.com/), further to the previously announced
decision to develop a Melem Secret Brand of Supplements and Natural
Health Products (press release March 4,
2010) the company is pleased to announce the launch of the
new product line.
New packaging has been developed in order to reflect the message
of "Natural Health and Well Being". The company designed a new
website with a fully functional ecommerce solution
www.melemsecret.com.
In other company news, HTDS retained the services of YMG
Consulting, a marketing firm based in Santa Monica, California, which specializes in
online ecommerce solutions. The new Melem Secret website is
equipped with some of the latest and innovative marketing software
available on the market.
Melem Secret is pleased to announce the nomination of Mr.
Ron Talley as Vice President of
Marketing. Ron brings with him 5 years of experience in creating
and sustaining successful large-scale marketing campaigns using
cutting edge marketing strategies and technologies.
Ron Talley Vice President
Marketing stated, "We are very proud of what we have accomplished
in the past 45 days. We have developed a concept and an image,
which we are very proud of. We have been able to assemble a team of
developers who really came through. Our goal is to increase
consumer awareness of our brand, which will result in profits for
the company."
Melem Secret's Natural Health Products will mainly target the
huge US dietary supplement market which is estimated at
$25 billion annually (source: Office
of Dietary Supplements). The company plans to introduce new
products regularly during 2010.
The company will shortly again subscribe to Pink Sheets filings
service where investors can view company filings and progress on
the Pink Sheets web site.
The company reminds its shareholders and followers to monitor
PinkSheets.com Filing section and also our IR company web site
http://www.minamargroup.net/ for non newsworthy corporate
updates.
For any matters relating to retail investor queries or to send
the company or its IR a message please click on the "INVESTOR
SUPPORT" TAB, or the direct link
http://www.minamargroup.net/helpdesk. In this regard, Mina Mar
Group works diligently to answer and address all the pressing
issues regarding its clients to the shareholders' satisfaction. MMG
is in constant contact with the companies, addressing, obtaining
and processing all inquiries. MMG is often one of the advisors or
IR companies utilized by the issuer. Depending on the location of
the issuer and management's availability, it may take up to several
days to address any pressing issues. In a normal course of business
and a pending transaction, the issuer may opt to remain silent in
order not to lose advantage to a competitor. MMG is mindful that
sometimes shareholders want answers immediately, which for the
above reasons cannot be fulfilled on a timely basis.
Don't be a victim. Report a stock basher to authorities. The
company is mindful that short sellers, the company competitors and
stock bashers stalk small cap Pink Sheets listed companies with
hidden agendas. Visit http://www.stockbasher.com/ and find out what
criminal and civil actions the US authorities are taking against
web sites like investorshub.com and other posters, and the remedies
available to you as an individual investor. MMG encourages the
readers to visit this investorshub.com blog and similar "investors"
web sites with an open mind. Discover for yourself why and how
USA based small businesses and the
backbone of the economy suffer. Stay informed and do not allow
entrepreneurs dreams, innovations, and their access to capital to
be thwarted as "scalpers" and day traders vigorously day in and day
out try to exploit and extinguish US innovation and progress for
quick profits.
Filings for this event are currently being reviewed and will be
filed with Pink Sheets and Client Support section in due course. To
be included in company's email database for press releases,
industry updates, and non-weekly activity in the company that may
or may not be news released, please subscribe or opt in mailer at
http://www.minamargroup.com/updates.
Safe Harbor Statement
Information in this news release may contain statements about
future expectations, plans, prospects or performance of Hard to
Treat Diseases Inc. that constitute forward-looking statements for
purposes of the Safe Harbor Provisions under the Private Securities
Litigation Reform Act of 1995. The words or phrases "can be",
"expects", "may affect", "believed", "estimate", "project" and
similar words and phrases are intended to identify such
forward-looking statements. Hard to Treat Diseases Inc. cautions
you that any forward-looking information provided by or on behalf
of Hard to Treat Diseases Inc. is not a guarantee of future
performance. None of the information in this press release
constitutes or is intended as an offer to sell securities or
investment advice of any kind. Hard to Treat Diseases Inc.'s actual
results may differ materially from those anticipated in such
forward-looking statements as a result of various important
factors, some of which are beyond Hard to Treat Diseases Inc.'s
control. In addition to those discussed in Hard to Treat Diseases
Inc.'s press releases, public filings, and statements by Hard to
Treat Diseases Inc.'s management, including, but not limited to,
Hard to Treat Diseases Inc.'s estimate of the sufficiency of its
existing capital resources, Hard to Treat Diseases Inc.'s ability
to raise additional capital to fund future operations, Hard to
Treat Diseases Inc.'s ability to repay its existing indebtedness,
the uncertainties involved in estimating market opportunities, and
in identifying contracts which match Hard to Treat Diseases Inc.'s
capability to be awarded contracts. All such forward-looking
statements are current only as of the date on which such statements
were made. Hard to Treat Diseases Inc. does not undertake any
obligation to publicly update any forward-looking statement to
reflect events or circumstances after the date on which any such
statement is made or to reflect the occurrence of unanticipated
events.
CONTACT: For any investor relations matters, please contact
www.minamargroup.net/helpdesk, Investor Relations Department
Inquiry, www.minamargroup.net (IR); For (M&A) and Corporate
Matters, www.minamargroup.com
SOURCE Hard to Treat Diseases